Thermo Fisher Scientific
TMO
911 hedge funds and large institutions have $43.2B invested in Thermo Fisher Scientific in 2014 Q2 according to their latest regulatory filings, with 56 funds opening new positions, 330 increasing their positions, 376 reducing their positions, and 55 closing their positions.
54% more call options, than puts
Call options by funds: $194M | Put options by funds: $126M
2% more first-time investments, than exits
New positions opened: 56 | Existing positions closed: 55
0.02% less ownership
Funds ownership: 92.55% → 92.53% (-0.02%)
0% less funds holding
Funds holding: 915 → 911 (-4)
1% less capital invested
Capital invested by funds: $43.6B → $43.2B (-$353M)
12% less repeat investments, than reductions
Existing positions increased: 330 | Existing positions reduced: 376
29% less funds holding in top 10
Funds holding in top 10: 82 → 58 (-24)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Norges Bank
Oslo,
Norway
|
+$340M |
| 2 |
MC
Montag & Caldwell
Atlanta,
Georgia
|
+$275M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$243M |
| 4 |
UBS AM
Chicago,
Illinois
|
+$234M |
| 5 |
GCM
Glenview Capital Management
New York
|
+$163M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CM
Corvex Management
New York
|
-$293M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$226M |
| 3 |
Viking Global Investors
Stamford,
Connecticut
|
-$164M |
| 4 |
PC
Paulson & Co
New York
|
-$157M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$118M |
TMO Hedge Fund Activity: Q2 2014 in Review
911 of the 3,480 institutional investors tracked by Wall St. Rank reported a position in Thermo Fisher Scientific (TMO) for Q2 2014, worth a combined $43.2B — down 0.81% from $43.6B a quarter earlier.
Buyers outnumbered sellers: 56 funds opened new TMO positions and 55 closed out — a net gain of 1 holder — while 330 added to existing stakes and 376 trimmed.
The largest buyer was Norges Bank, adding an estimated $340M. The largest seller was Corvex Management, exiting entirely with an estimated $293M sold.
- 911 institutional investors held Thermo Fisher Scientific (TMO) as of Q2 2014, down from 915 in Q1 2014.
- Funds reported $43.2B of Thermo Fisher Scientific stock for Q2 2014, down 0.81% quarter-over-quarter.
- 56 funds opened new Thermo Fisher Scientific positions in Q2 2014 and 55 closed out, a net change of +1 holder.
- The largest Thermo Fisher Scientific buyer in Q2 2014 was Norges Bank, an estimated $340M added.
- The largest Thermo Fisher Scientific seller in Q2 2014 was Corvex Management, an estimated $293M sold.
Based on aggregated 13F filings for Q2 2014.